Lisanti资本增长有限责任公司在NewAmsterdam Pharma的股份增加了近27%,现在持有49 110股。 Lisanti Capital Growth LLC boosted its stake in NewAmsterdam Pharma by nearly 27%, now holding 49,110 shares.

利桑蒂资本增长有限公司在第一季度将新阿姆斯特丹制药公司的股份增加了26.9%,目前拥有49 110股。 Lisanti Capital Growth LLC increased its holdings in NewAmsterdam Pharma by 26.9% during the first quarter, now owning 49,110 shares. 该公司目前的股票交易额为每股18.57美元,50天移动平均18.72美元。 The company's stock is currently trading at $18.57 per share with a 50-day moving average of $18.72. 新阿姆斯特丹制药公司开发了新陈代谢疾病的治疗方法,市场上限为20.8亿美元。 NewAmsterdam Pharma develops therapies for metabolic diseases and has a market cap of $2.08 billion. 股价为42.89美元的目标价。 The stock has a consensus "Moderate Buy" rating with a target price of $42.89.